These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 17035369

  • 1. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I, Inoue M, Okuda K, Ando Y, Muto S, Kusano E.
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinase levels in the drained dialysate reflect the peritoneal solute transport rate: a multicentre study in Japan.
    Hirahara I, Inoue M, Umino T, Saito O, Muto S, Kusano E.
    Nephrol Dial Transplant; 2011 May; 26(5):1695-701. PubMed ID: 20921293
    [Abstract] [Full Text] [Related]

  • 3. A case of encapsulating peritoneal sclerosis at the clinical early stage with high concentration of matrix metalloproteinase-2 in peritoneal effluent.
    Masunaga Y, Hirahara I, Shimano Y, Kurosu M, Iimura O, Miyata Y, Amemiya M, Homma S, Kusano E, Asano Y.
    Clin Exp Nephrol; 2005 Mar; 9(1):85-9. PubMed ID: 15830280
    [Abstract] [Full Text] [Related]

  • 4. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.
    Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, Kin M, Nakamoto M, Ohira S, Shoji T.
    Am J Kidney Dis; 2004 Oct; 44(4):729-37. PubMed ID: 15384025
    [Abstract] [Full Text] [Related]

  • 5. Encapsulating peritoneal sclerosis.
    Kawanishi H.
    Nephrology (Carlton); 2005 Jun; 10(3):249-55. PubMed ID: 15958037
    [Abstract] [Full Text] [Related]

  • 6. Fibrin degradation products are a useful marker for the risk of encapsulating peritoneal sclerosis.
    Moriishi M, Kawanishi H.
    Adv Perit Dial; 2008 Jun; 24():56-9. PubMed ID: 18986002
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS, Martins M, Korevaar JC, Silva S, Oliveira JC, Cabrita A, Castro e Melo J, Krediet RT.
    Am J Nephrol; 2007 Jun; 27(1):84-91. PubMed ID: 17284895
    [Abstract] [Full Text] [Related]

  • 8. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V, Limardo M, Cavalli A, Crepaldi M, Locatelli F.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [Abstract] [Full Text] [Related]

  • 9. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis.
    Hendriks MP, de Sévaux RG, Hilbrands LB.
    Neth J Med; 2008 Sep; 66(7):269-74. PubMed ID: 18663253
    [Abstract] [Full Text] [Related]

  • 10. Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats.
    Hirahara I, Ogawa Y, Kusano E, Asano Y.
    Nephrol Dial Transplant; 2004 Jul; 19(7):1732-41. PubMed ID: 15128883
    [Abstract] [Full Text] [Related]

  • 11. What does the dialysate level of matrix metalloproteinase 2 tell us?
    Ertilav M, Timur O, Hür E, Bozkurt D, Nar H, Kologlu T, Sen S, Duman S.
    Adv Perit Dial; 2011 Jul; 27():6-10. PubMed ID: 22073820
    [Abstract] [Full Text] [Related]

  • 12. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment.
    Yamamoto R, Nakayama M, Hasegawa T, Miwako N, Yamamoto H, Yokoyami K, Ikeda M, Kato N, Hayakawa H, Takahashi H, Otsuka Y, Kawaguchi Y, Hosoya T.
    Adv Perit Dial; 2002 Jul; 18():131-4. PubMed ID: 12402604
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.
    Yamamoto R, Otsuka Y, Nakayama M, Maruyama Y, Katoh N, Ikeda M, Yamamoto H, Yokoyama K, Kawaguchi Y, Matsushima M.
    Clin Exp Nephrol; 2005 Jun; 9(2):148-52. PubMed ID: 15980950
    [Abstract] [Full Text] [Related]

  • 14. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis in Slovenia.
    Lindic J, Rupnik AT, Tomazic J, Skoberne A, Gucek A, Ferluga D, Pintar T, Ales A, Kovac D, Kveder R, Pajek J, Savicki-Ponikvar B, Bren A.
    Ther Apher Dial; 2009 Aug; 13(4):282-7. PubMed ID: 19695060
    [Abstract] [Full Text] [Related]

  • 15. Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients.
    Alscher DM, Braun N, Biegger D, Fritz P.
    Am J Kidney Dis; 2007 Mar; 49(3):452-61. PubMed ID: 17336707
    [Abstract] [Full Text] [Related]

  • 16. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M, Endoh M, Suzuki D, Tanabe R, Endoh H, Hirahara I, Sakai H.
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [Abstract] [Full Text] [Related]

  • 17. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.
    Bozkurt D, Taskin H, Sezak M, Biçak S, Sen S, Ok E, Duman S.
    Adv Perit Dial; 2008 Dec; 24():32-8. PubMed ID: 18985998
    [Abstract] [Full Text] [Related]

  • 18. Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis.
    Moriishi M, Kawanishi H, Kawai T, Takahashi S, Hirai T, Shishida M, Watanabe H, Takahashi N.
    Adv Perit Dial; 2002 Dec; 18():149-53. PubMed ID: 12402608
    [Abstract] [Full Text] [Related]

  • 19. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS, Aguilera A, Selgas R, Ramírez-Huesca M, Pérez-Lozano ML, Cirugeda A, Bajo MA, del Peso G, Sánchez-Tomero JA, Jiménez-Heffernan JA, López-Cabrera M.
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [Abstract] [Full Text] [Related]

  • 20. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients.
    Ekim M, Fitöz S, Yagmurlu A, Ensari A, Yüksel S, Acar B, Ozçakar ZB, Kendirli T, Bingöler B, Yalçinkaya F.
    Nephrology (Carlton); 2005 Aug; 10(4):341-3. PubMed ID: 16109078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.